View in EDS

Oncogene inactivation-induced senescence facilitates tumor relapse.

Saved in:
Bibliographic Details
Title: Oncogene inactivation-induced senescence facilitates tumor relapse.
Authors: Schmitt P; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Buch, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany., Hönig K; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Norcia MT; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Nogueira MF; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Flore V; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK., Vesperinas IS; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Villoro-Agud M; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Peng L; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Safyürek Z; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Tariq M; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Milojkovic A; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Translational Microbiome Research, Internal Medicine I and M3 Research Center, University Hospital Tuebingen, Tübingen, Germany., Anders K; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Pediatric Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Schröck E; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), partner site: Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Sauer S; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany., Uyar B; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Akalin A; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Willimsky G; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Buch, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany., Haas S; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; Cluster of Excellence ImmunoPreCept, Charité - Universitätsmedizin Berlin, Berlin, Germany., Martínez-Reyes I; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. i.m.reyes@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de.; Cluster of Excellence ImmunoPreCept, Charité - Universitätsmedizin Berlin, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de., Blankenstein T; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. tblanke@mdc-berlin.de.
Source: Nature communications [Nat Commun] 2026 Jul 15; Vol. 17 (1). Date of Electronic Publication: 2026 Jul 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42457681
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oncogene inactivation-induced senescence facilitates tumor relapse.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schmitt+P%22">Schmitt P</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Buch, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hönig+K%22">Hönig K</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Norcia+MT%22">Norcia MT</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Nogueira+MF%22">Nogueira MF</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Flore+V%22">Flore V</searchLink>; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Vesperinas+IS%22">Vesperinas IS</searchLink>; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Villoro-Agud+M%22">Villoro-Agud M</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Peng+L%22">Peng L</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Safyürek+Z%22">Safyürek Z</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Tariq+M%22">Tariq M</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Milojkovic+A%22">Milojkovic A</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Translational Microbiome Research, Internal Medicine I and M3 Research Center, University Hospital Tuebingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Anders+K%22">Anders K</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Pediatric Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schröck+E%22">Schröck E</searchLink>; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), partner site: Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Sauer+S%22">Sauer S</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Uyar+B%22">Uyar B</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Akalin+A%22">Akalin A</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Willimsky+G%22">Willimsky G</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Buch, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Haas+S%22">Haas S</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; Cluster of Excellence ImmunoPreCept, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Martínez-Reyes+I%22">Martínez-Reyes I</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. i.m.reyes@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de.; Cluster of Excellence ImmunoPreCept, Charité - Universitätsmedizin Berlin, Berlin, Germany. i.m.reyes@dkfz-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Blankenstein+T%22">Blankenstein T</searchLink>; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. tblanke@mdc-berlin.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Jul 15; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Jul 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42457681
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-026-75021-9
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Oncogene inactivation-induced senescence facilitates tumor relapse.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schmitt P
      – PersonEntity:
          Name:
            NameFull: Hönig K
      – PersonEntity:
          Name:
            NameFull: Norcia MT
      – PersonEntity:
          Name:
            NameFull: Nogueira MF
      – PersonEntity:
          Name:
            NameFull: Flore V
      – PersonEntity:
          Name:
            NameFull: Vesperinas IS
      – PersonEntity:
          Name:
            NameFull: Villoro-Agud M
      – PersonEntity:
          Name:
            NameFull: Peng L
      – PersonEntity:
          Name:
            NameFull: Safyürek Z
      – PersonEntity:
          Name:
            NameFull: Tariq M
      – PersonEntity:
          Name:
            NameFull: Milojkovic A
      – PersonEntity:
          Name:
            NameFull: Anders K
      – PersonEntity:
          Name:
            NameFull: Schröck E
      – PersonEntity:
          Name:
            NameFull: Sauer S
      – PersonEntity:
          Name:
            NameFull: Uyar B
      – PersonEntity:
          Name:
            NameFull: Akalin A
      – PersonEntity:
          Name:
            NameFull: Willimsky G
      – PersonEntity:
          Name:
            NameFull: Haas S
      – PersonEntity:
          Name:
            NameFull: Martínez-Reyes I
      – PersonEntity:
          Name:
            NameFull: Blankenstein T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 2026 Jul 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1